Organization · Venture Capital
RNK.VC
RNK.VC is a Dubai-based venture capital fund that invests in early-stage companies at the intersection of biology, physics, and engineering, focusing on biotech, deeptech, and agrotech.
Overview
What RNK.VC does
What RNK.VC is
RNK.VC is a Dubai-based venture capital fund that invests in early-stage companies at the intersection of biology, physics, and engineering, focusing on biotech, deeptech, and agrotech.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2023
- Approximate age
- About 3 years
- Structured capabilities
- Funder
- Last reviewed
- May 5, 2026
Official channels
Find RNK.VC elsewhere
Open the official website or a supported primary organization account.
Capability profile
RNK.VC as a funder
Investment thesis
RNK.VC backs science that matters, focusing on pre-seed and seed founders engineering biology, materials, and energy systems.
Focus narrative
RNK.VC invests in foundational systems rather than specific categories, focusing on areas such as biological infrastructure, health and diagnostics, energy and materials, food and ecosystems, and intelligence and robotics. The fund seeks to support companies that are innovating in these fields, particularly those that can demonstrate strong technical moats and scientific defensibility.
Value beyond capital
RNK.VC provides not only capital but also strategic support to its portfolio companies, leveraging its expertise in science and technology to help founders navigate the complexities of bringing innovative products to market. The firm emphasizes the importance of scientific research and technical innovation as the foundation for building defensible and scalable businesses.
Terms and economics
- Typical check
- $100,000–$500,000
Focus and fit
- Stages
- Pre-seed · Seed
- Sectors
- Biotech & Life SciencesSynthetic BiologyHealthcareEnergyRobotics & Autonomous SystemsArtificial Intelligence
- Regions
- Mena · Global
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 6
Portfolio context
Moinology: Innovating in microprotein production for Earth and Mars, integrating foodtech and biotech. Ergamin: Developing advanced technology for amino acid hydrolysis. Termyx: Specializing in advanced materials derived from the space industry. Biovolf: Focusing on the future of plant-based protein. Arcticberry: Engaging in microcloning of Arctic berries. Thalugen: Producing marine microalgae supplements aimed at improving eye, heart, and brain health, featuring a proprietary strain known as Nanno5.
Common questions
What to know about RNK.VC
Upseed classifies RNK.VC under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 5, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.